Pulmonary Vasculitis Update /
Review
Part 2: Treatment and Prognosis
By Brett Ley. MD. PulmCCM.org January 16, 2013
"Treatment of the ANCA-associated pulmonary vasculitides consists of systemic corticosteroids and cytotoxic therapies given in two phases, induction and maintenance, where the aggressiveness of the regimen is based on disease severity.
Fuente:
Frankel S. & Schwartz M. The Pulmonary Vasculidities. AJRCCM 2012;186:216-224.